Your browser doesn't support javascript.
loading
Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
Biswal, Shibadas; Borja-Tabora, Charissa; Martinez Vargas, Luis; Velásquez, Hector; Theresa Alera, Maria; Sierra, Victor; Johana Rodriguez-Arenales, Edith; Yu, Delia; Wickramasinghe, V Pujitha; Duarte Moreira, Edson; Fernando, Asvini D; Gunasekera, Dulanie; Kosalaraksa, Pope; Espinoza, Felix; López-Medina, Eduardo; Bravo, Lulu; Tuboi, Suely; Hutagalung, Yanee; Garbes, Pedro; Escudero, Ian; Rauscher, Martina; Bizjajeva, Svetlana; LeFevre, Inge; Borkowski, Astrid; Saez-Llorens, Xavier; Wallace, Derek.
Affiliation
  • Biswal S; Takeda Vaccines, Boston, MA, USA. Electronic address: shibadas.biswal@takeda.com.
  • Borja-Tabora C; Research Institute For Tropical Medicine, Muntinlupa, Philippines.
  • Martinez Vargas L; Centro de Atención e Investigación Médica, Dominicana, Santo Domingo, Dominican Republic.
  • Velásquez H; Centro de Atención e Investigación Médica, Acacias, Colombia.
  • Theresa Alera M; Philippines-Armed Forces Research Institute of Medical Sciences Virology Research Unit, Cebu City, Philippines.
  • Sierra V; Centro de Atención e Investigación Médica, Yopal, Colombia.
  • Johana Rodriguez-Arenales E; Centro de Atención e Investigación Médica, Aguazul, Colombia.
  • Yu D; De La Salle Medical and Health Sciences Institute, Dasmariñas, Philippines.
  • Wickramasinghe VP; University of Colombo, Colombo, Sri Lanka.
  • Duarte Moreira E; Associação Obras Sociais Irmã Dulce Hospital Santo Antônio and Oswaldo Cruz Foundation, Bahia, Brazil.
  • Fernando AD; Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka.
  • Gunasekera D; Faculty of Medical Sciences, University of Sri Jayawardenenpura, Gangodawila, Sri Lanka.
  • Kosalaraksa P; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Espinoza F; National Autonomous University of Nicaragua, León, Nicaragua.
  • López-Medina E; Centro de Estudios en Infectología Pediátrica, Universidad del Valle and Centro Médico Imbanaco, Cali, Colombia.
  • Bravo L; University of the Philippines Manila, Ermita, Philippines.
  • Tuboi S; Takeda Pharmaceuticals, São Paulo, Brazil.
  • Hutagalung Y; Takeda Vaccines, Singapore.
  • Garbes P; Takeda Vaccines, Boston, MA, USA.
  • Escudero I; Takeda Vaccines, Singapore.
  • Rauscher M; Takeda Pharmaceuticals International, Zurich, Switzerland.
  • Bizjajeva S; Takeda Pharmaceuticals International, Zurich, Switzerland.
  • LeFevre I; Takeda Pharmaceuticals International, Zurich, Switzerland.
  • Borkowski A; Takeda Pharmaceuticals International, Zurich, Switzerland.
  • Saez-Llorens X; Hospital del Niño Dr José Renán Esquivel, Sistema Nacional de Investigación at Secretaría Nacional de Ciencia y Tecnología, Centro de Vacunación Internacional (Cevaxin), Panama City, Panama.
  • Wallace D; Takeda Vaccines, Boston, MA, USA.
Lancet ; 395(10234): 1423-1433, 2020 05 02.
Article in En | MEDLINE | ID: mdl-32197105

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Dengue / Dengue Virus / Dengue Vaccines Type of study: Clinical_trials / Guideline Limits: Adolescent / Child / Child, preschool / Humans Country/Region as subject: America central / America do sul / Asia / Brasil / Colombia / Nicaragua / Panama / Republica dominicana Language: En Journal: Lancet Year: 2020 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Dengue / Dengue Virus / Dengue Vaccines Type of study: Clinical_trials / Guideline Limits: Adolescent / Child / Child, preschool / Humans Country/Region as subject: America central / America do sul / Asia / Brasil / Colombia / Nicaragua / Panama / Republica dominicana Language: En Journal: Lancet Year: 2020 Document type: Article Country of publication: